Despite the low ROE, Tianjin Chase Sun PharmaceuticalLtd's respectable earnings growth can be attributed to its efficient reinvestment of profits. The company's future growth rate is expected to maintain its current pace according to industry analyst forecasts.
紅日藥業股票討論區
中國 股票:前 8 期
$包鋼股份 (600010.SH)$
$三峽能源 (600905.SH)$
$永泰能源 (600157.SH)$
$ST愛康 (002610.SZ)$
$ST航高 (002665.SZ)$
$紅日藥業 (300026.SZ)$
$中國能建 (601868.SH)$
...
暫無評論